Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000234248 | SCV000288653 | likely benign | Oligodontia-cancer predisposition syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697232 | SCV000525136 | likely benign | not provided | 2021-04-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001010837 | SCV001171091 | likely benign | Hereditary cancer-predisposing syndrome | 2019-02-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001824701 | SCV002074522 | likely benign | not specified | 2022-01-04 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001697232 | SCV004218972 | benign | not provided | 2023-06-05 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000234248 | SCV005403151 | benign | Oligodontia-cancer predisposition syndrome | 2024-07-02 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV004541419 | SCV004776216 | likely benign | AXIN2-related disorder | 2020-01-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |